Correction to: Pharmacokinetic Profile of Gilteritinib: A Novel FLT-3 Tyrosine Kinase Inhibitor (Clinical Pharmacokinetics, (2020), 59, 10, (1273-1290), 10.1007/s40262-020-00888-w)

Angela Joubert James, Catherine C. Smith, Mark Litzow, Alexander E. Perl, Jessica K. Altman, Dale Shepard, Takeshi Kadokura, Kinya Souda, Melanie Patton, Zheng Lu, Chaofeng Liu, Selina Moy, Mark J. Levis, Erkut Bahceci

Research output: Contribution to journalComment/debatepeer-review

Abstract

In Table 8 of this article, the data in the column headed “Fed Geometric LS Mean” were mistakenly listed under column heading “Fasted Geometric LS Mean”and vice versa. The correct Table 8 is as follows: (Table presented.).

Original languageEnglish (US)
Pages (from-to)1251
Number of pages1
JournalClinical Pharmacokinetics
Volume60
Issue number9
DOIs
StatePublished - Sep 2021

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Correction to: Pharmacokinetic Profile of Gilteritinib: A Novel FLT-3 Tyrosine Kinase Inhibitor (Clinical Pharmacokinetics, (2020), 59, 10, (1273-1290), 10.1007/s40262-020-00888-w)'. Together they form a unique fingerprint.

Cite this